Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Change in Inventory (2016 - 2025)

Historic Change in Inventory for Conmed (CNMD) over the last 16 years, with Q4 2025 value amounting to -$8.5 million.

  • Conmed's Change in Inventory fell 21822.98% to -$8.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $6.7 million, marking a year-over-year decrease of 7871.53%. This contributed to the annual value of $6.7 million for FY2025, which is 7871.53% down from last year.
  • According to the latest figures from Q4 2025, Conmed's Change in Inventory is -$8.5 million, which was down 21822.98% from $2.2 million recorded in Q3 2025.
  • Conmed's Change in Inventory's 5-year high stood at $26.4 million during Q4 2022, with a 5-year trough of -$8.8 million in Q4 2023.
  • Moreover, its 5-year median value for Change in Inventory was $5.3 million (2021), whereas its average is $7.0 million.
  • As far as peak fluctuations go, Conmed's Change in Inventory soared by 237885.09% in 2024, and later crashed by 21822.98% in 2025.
  • Conmed's Change in Inventory (Quarter) stood at $3.1 million in 2021, then skyrocketed by 745.47% to $26.4 million in 2022, then plummeted by 133.23% to -$8.8 million in 2023, then skyrocketed by 181.92% to $7.2 million in 2024, then tumbled by 218.23% to -$8.5 million in 2025.
  • Its last three reported values are -$8.5 million in Q4 2025, $2.2 million for Q3 2025, and $5.6 million during Q2 2025.